Depends on the results.
1. If the data on tumor reduction in the Direct trial is complete tumor reduction plus strong indications of systemic immune responses, and these results keep trickling out week after week on cancer type after cancer type, at some point the PPS (as well as the market cap) will explode.
2. If the 1st or 2nd interim data in the DCVAX- L trial are so strong that the trial is unblinded, the price will explode.
Market Cap is important for PPS, and I regret not being more clear on my first post regarding what PPS would do without further dilution.
Regardless, the upshot of mine and the others' last posts on calculating Market Cap to PPS are in agreement.
That said….
In my opinion, we will sail beyond a 7 billion market cap in very little time with positive news on numbers 1 or 2 above (and no bad news).
So if we go over 7 billion Market Cap, we will also be comfortably beyond $100.00 per share, as long as there are no new offerings between now and then. This PPS includes what the others wanted me to include the first time around -- existing warrants and options that will be exercised long before we reach $100.00 per share. Their figures would agree with this extrapolation.
So what does a 7 Billion Market share mean? If you know these companies, and what they produce or have in their pipeline, you can get a feel for what this number means. There are better examples, but this list is just a starting point.
1. CLDX = 1.88 Billion
2. CBST = 5.18 Billion
3. JAZZ = 7.86 Billion
4. PCYC = 9.62 Billion
5. Gilead =113 Billion
6. Roche = 242 Billion
AI
Market Data 
Markets 
